Related Experiment Videos
A propensity matched study of New York Heart Association class and natural history end points in heart failure
1University of Alabama at Birmingham, Birmingham, Alabama, USA. aahmed@uab.edu
Insights
Higher New York Heart Association (NYHA) functional class in heart failure (HF) patients is linked to increased mortality and hospitalizations. This study confirms NYHA class as a significant predictor of adverse outcomes in ambulatory HF patients.
Area of Science:
- Cardiology
- Clinical Medicine
- Public Health
Background:
- The New York Heart Association (NYHA) functional class is a known indicator of poor prognosis in heart failure (HF).
- The extent to which covariates like age, disease severity, and comorbidities confound this association remains unclear.
- Understanding these associations is crucial for risk stratification and management of chronic HF.
Purpose of the Study:
- To quantify the association between higher NYHA functional class (III/IV) and adverse outcomes in chronic heart failure (HF).
- To assess the impact of NYHA class on mortality and hospitalization rates, adjusting for potential confounders.
- To determine if NYHA class independently predicts outcomes in ambulatory HF patients.
Main Methods:
- Utilized data from the Digitalis Investigation Group (DIG) trial, including 7,788 patients with chronic HF.
- Calculated propensity scores for NYHA classes III and IV to match patients.
- Matched 1,863 patients in NYHA classes III/IV with 1,863 patients in NYHA classes I/II.
- Employed Kaplan-Meier and matched Cox regression analyses for outcome estimation.
Main Results:
- Patients in NYHA classes III/IV had a significantly higher all-cause mortality rate (42% vs. 34%) compared to those in NYHA classes I/II (HR 1.29, p <0.0001).
- All-cause hospitalizations were also higher in NYHA classes III/IV (71% vs. 66%) (HR 1.16, p = 0.003).
- Specific hazard ratios for NYHA classes III/IV included: cardiovascular mortality (1.29), HF mortality (1.49), cardiovascular hospitalization (1.18), and HF hospitalization (1.17).
Conclusions:
- Baseline NYHA functional class is a significant independent predictor of mortality and hospitalization in ambulatory patients with chronic HF.
- Higher NYHA classes (III/IV) are robustly associated with increased risks of all-cause and cause-specific mortality and hospitalizations.
- NYHA class serves as a critical marker for disease progression and prognosis in a broad spectrum of HF patients.
Abstract:
The association between higher New York Heart Association (NYHA) functional class and poor outcome in heart failure (HF) is well known. However, to what extent these associations are confounded by covariates such as age, the severity of disease, and co-morbidity burden is unknown. In the Digitalis Investigation Group (DIG) trial, 2,441 of the 7,788 patients with chronic HF had NYHA class III or IV symptoms. Propensity scores for NYHA classes III and IV were calculated for each patient and were then used to match 1,863 patients in NYHA classes III and IV with 1,863 patients in NYHA classes I and II. Kaplan-Meier and matched Cox regression analyses were used to estimate associations of NYHA class III or IV with mortality and hospitalizations during a median of 37 months of follow-up. Compared with 34% (641 of 1,863) patients in NYHA classes I and II (mortality rate 1,175 in 10,000 person-years of follow-up), 42% (777 of 1,863) patients in NYHA classes III and IV (mortality rate 1,505 in 10,000 person-years) died from all causes (hazard ratio 1.29, 95% confidence interval [CI] 1.14 to 1.45, p <0.0001). Hospitalizations due to all causes occurred in 66% (1,232 of 1,863) patients in NYHA classes I and II (hospitalization rate 3,898 in 10,000 person-years) and 71% (1,322 of 1,863) patients in NYHA classes III and IV (hospitalization rate 4,793 in 10,000 person-years) (hazard ratio 1.16, 95% CI 1.05 to 1.28, p = 0.003). The hazard ratios for patients in NYHA classes III and IV, compared with those for those in NYHA classes I and II, for other outcomes were 1.29 for cardiovascular mortality (95% CI 1.12 to 1.48, p <0.0001), 1.49 for HF mortality (95% CI 1.20 to 1.84, p <0.0001), 1.18 for cardiovascular hospitalization (95% CI 1.06 to 1.32, p = 0.002), and 1.17 for HF hospitalization (95% CI 1.03 to 1.34, p = 0.017). In conclusion, baseline NYHA class is a marker of hospitalization, disease progression, and mortality in a wide spectrum of ambulatory patients with chronic HF.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care